Literature DB >> 8639932

High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement.

P Moreau, N Milpied, P de Faucal, T Petit, P Herbouiller, R Bataille, J L Harousseau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8639932

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Secondary and Infiltrative Cardiomyopathies.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-10

2.  Amyloidosis 2008 BMT Tandem Meetings (February 13-17, San Diego).

Authors:  Angela Dispenzieri; Giampaolo Merlini; Raymond L Comenzo
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

3.  [Systemic Al-amyloidosis. Clinical course and limits of melphalan therapy].

Authors:  G R Hetzel; P Heering; B Grabensee
Journal:  Med Klin (Munich)       Date:  1999-10-15

4.  Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract.

Authors:  Marit Mejhert; Robert Hast; Benngt Sandstedt; Izabella Janczewska
Journal:  BMJ Case Rep       Date:  2011-08-17

Review 5.  [Transplantation of hematopoietic stem cells. II: Indications for transplantation of hematopoietic stem cells after myeloablative therapy].

Authors:  H Link; H J Kolb; W Ebell; D K Hossfeld; A Zander; D Niethammer; H Wandt; H Grosse-Wilde; U W Schaefer
Journal:  Med Klin (Munich)       Date:  1997-09-15

6.  Cardiac Amyloidosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.